Skip to main content
. 2023 Dec 23;12(1):21. doi: 10.3390/vaccines12010021

Figure 1.

Figure 1

Structures of INI-4001 (A), a lipidated oxoadenine and a TLR 7/8 agonist, and INI-2002 (B), a synthetic TLR 4 agonist.